Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: JAMA Ophthalmol. 2015 Feb;133(2):182–190. doi: 10.1001/jamaophthalmol.2014.4747

Figure 2. Characterization of scAAV2.dnRhoA Gene Transfer.

Figure 2

A, Actin-stained human trabecular meshwork (TM) cells infected with scAAV2.dnRhoA (top) and vehicle-treated ones (bottom). B, Iridocorneal sections from rats injected with scAAV2.dnRhoA (top) or control scAAV2.GFP (bottom). C, Human RhoA normalized expression in scAAV2.dnRhoA-injected and control scAAV2.GFP eyes. Data are given as mean (SE). D, Fluorescence image from control scAAV2.GFP-injected eyes.

a Indicates P < .05.